We have recently identified from the avian hypothalamus a complementary DNA encoding a small secretory protein termed neurosecretory protein GL (NPGL). In chicks, NPGL increases body weight gain without affecting food intake. A database search reveals that NPGL is conserved throughout vertebrates. However, the central distribution and functional role of NPGL remains to be elucidated in mammals. In this study, we identified the precursor complementary DNA encoding NPGL from the mouse hypothalamus. Quantitative reverse transcription polymerase chain reaction and morphological analyses revealed that NPGL precursor messenger RNA is robustly expressed in the mediobasal hypothalamus with NPGL neurons specifically localized to the lateroposterior part of the arcuate nucleus in the hypothalamus. NPGL-immunoreactive fibers were observed in close anatomical contact with pro-opiomelanocortin neurons in the rostral region of the arcuate nucleus. NPGL messenger RNA expression was elevated by 24-hour fasting and reduced by feeding of a highfat diet for 5 weeks. Furthermore, intracerebroventricular injection of mature NPGL increased food intake, pointing to an important role in feeding. Taken together, these findings report on the distribution of NPGL in the mammalian brain and point to an important role for this neuropeptide in energy homeostasis. (Endocrinology 158: 1120(Endocrinology 158: -1129(Endocrinology 158: , 2017 T he discovery of leptin, an anorexigenic peptide hormone secreted from adipose tissues (1), helped to clarify the means by which body composition is communicated to central structures that regulate feeding and metabolism. Leptin exerts its effect via two major neuronal populations, that is, orexigenic neuropeptide Y (NPY)/agouti-related protein (AgRP) neurons and anorexigenic pro-opiomelanocortin (POMC) neurons in the arcuate nucleus (Arc) of the hypothalamus (2). In addition to leptin, ghrelin, an orexigenic peptide hormone secreted mainly from the gastric tissue, acts on NPY/AgRP neurons (3) to increase feeding.
T he discovery of leptin, an anorexigenic peptide hormone secreted from adipose tissues (1), helped to clarify the means by which body composition is communicated to central structures that regulate feeding and metabolism. Leptin exerts its effect via two major neuronal populations, that is, orexigenic neuropeptide Y (NPY)/agouti-related protein (AgRP) neurons and anorexigenic pro-opiomelanocortin (POMC) neurons in the arcuate nucleus (Arc) of the hypothalamus (2) . In addition to leptin, ghrelin, an orexigenic peptide hormone secreted mainly from the gastric tissue, acts on NPY/AgRP neurons (3) to increase feeding.
Feeding is further controlled by hypothalamic orexin, also called hypocretin, cells that are directly targeted by leptin and ghrelin (4) . In turn, orexin cells innervate a number of neuronal phenotypes, including histaminergic, serotonergic, and dopaminergic neurons (4) . Despite considerable progress in understanding the regulation of hunger and satiety during the last several decades, the neural control of feeding is not completely understood. To further understanding of the mechanism regulating feeding behavior, we sought to identify previously unknown hypothalamic neuropeptides.
To find neuropeptide precursors in the vertebrate brain, we performed a complementary DNA (cDNA) subtractive screen of the chicken hypothalamic infundibulum, which contains one of the feeding centers in this species. After sequencing 596 clones, we identified a cDNA encoding a previously unknown small protein and termed this neurochemical neurosecretory protein GL (NPGL) because the precursor protein contained a secretory signal sequence at the N terminus and the predicted C-terminal amino acids of the small protein were Gly-Leu-NH 2 (5) . In chicks, subcutaneous chronic infusion of NPGL induces a significant increase in body weight gain without affecting food intake, suggesting a central role for this protein in regulating growth in this species (5) . A database search revealed that the gene for NPGL is conserved in vertebrates, including humans, rats, and mice. Given the role of NPGL in chick body weight regulation, we speculated that the mammalian homolog of NPGL might play an important role in feeding and/or energy metabolism. As a result, the present investigation sought to characterize whether NPGL is in a position to interact with well-established feeding circuitry and impact food intake. To accomplish this goal, we first cloned the cDNA encoding NPGL from the mouse hypothalamus and investigated the distribution of NPGL neurons throughout the brain. To explore the role of NPGL in monitoring energetic state, the expression of NPGL precursor messenger RNA (mRNA) was examined during fasting and in animals provided with a high-fat diet (HFD). Finally, the role of NPGL on feeding was explored by investigating the effect of intracerebroventricular injections of NPGL on food intake.
Materials and Methods

Animals
C57BL/6J mice were purchased from Charles River Laboratories (Kanagawa, Japan) and housed in standard conditions (23 6 2°C under a 12-hour light/12-hour dark cycle) with ad libitum access to water and normal chow (CE-2; CLEA Japan, Tokyo, Japan). Mice fed a HFD (D12492; Research Diets, New Brunswick, NJ) for either 5 or 13 weeks beginning at 4 weeks of age were also purchased from Charles River Laboratories. All animal experiments were performed according to the Guide for the Care and Use of Laboratory Animals prepared by Hiroshima University (Higashi-Hiroshima, Japan).
Molecular cloning of cDNA encoding NPGL
Male mice (8 weeks old) were used. The methods used to clone NPGL have been described previously (6-9) and are briefly described herein. Preliminary results revealed that the NPGL precursor mRNA was highly expressed in the mediobasal hypothalamus (MBH). Therefore, cDNA synthesized from total RNA in the MBH was used as a source for cloning. Primers were designed based on the genomic sequence data (chromosome 1; accession no. AL645534 no. 68,608 to 68,627), and the anchor primer. These secondround PCR products were subcloned into a TA cloning vector (pGEM-T Easy; Promega, Madison, WI) in accordance with the manufacturer's instructions. The DNA inserts of the positive clones were amplified by PCR with universal M13 primers. The nucleotide sequence was determined using an ABI Prism dye terminator cycle sequencing ready reaction kit (Applied Biosystems, Foster City, CA) and a model 310 automated DNA sequencer (Applied Biosystems), and then analyzed with DNASIS Pro software (Hitachi Software Engineering, Kanagawa, Japan). Universal M13 primers or gene-specific primers were used to sequence both strands.
Real-time reverse transcription PCR
Male mice (8 weeks old) were killed to examine the distribution of NPGL mRNA throughout the brain (telencephalon, diencephalon, mesencephalon, cerebellum, and MBH). Additionally, the MBH from mice (9 and 17 weeks old) fed HFD for 5 and 13 weeks were also used. The tissues were frozen in liquid nitrogen and stored at 280°C for RNA processing. Total RNA was isolated with TRIzol regent (Life Technologies, Carlsbad, CA). RNA concentration was measured by nanodrop spectroscopy (Thermo Fisher Scientific, Waltham, MA), and cDNA was reverse transcribed using ReverTra Ace quantitative reverse transcription PCR (RT-PCR) master mix with genomic DNA remover (Toyobo, Osaka, Japan). PCR amplifications were performed with THUNDERBIRD SYBR quantitative PCR mix (Toyobo) using following conditions: 95°C for 20 seconds, followed by 40 cycles of 95°C for 3 seconds, and 60°C for 30 seconds. b-Actin (ACTB) was used as an endogenous control. The following primers were used: NPGL sense primer, 5 0 -GGAACCATGGCTTAGGAAGG-3 0 (nucleotide no. 326 to 345 from the ATG initiation codon), antisense primer, 5 0 -TCTAAGGAGCTGAGAATATGCA-3 0 (nucleotide no. 435 to 414); suppressor of cytokine signaling 3 (Socs3) sense primer, 
In situ hybridization
Male mice (8 weeks old) were transcardially perfused with 0.9% saline followed by 4% paraformaldehyde. The brains were postfixed overnight and then put in sucrose solution (30% in 10 mM phosphate buffer) at 4°C until they sank. The brains were cut at 16-mm thickness with a cryostat at 220°C. Digoxigenin-labeled antisense and sense RNA probes were produced from a cloned PCR fragment (376 bp) with the sense primer, 5 0 -GTTCATTGTGGGAATATGCT-3 0 (nucleotide no. 60 to 79), and the antisense primer, 5 0 -TCTAAGGAGCTGAGAATATGCA-3 0 (nucleotide no. 435 to 414), using the digoxigenin RNA labeling kit (SP6/T7; Roche Diagnostics). Labeling was accomplished as previously described (6, 7).
Production of NPGL and antibody against NPGL
The deduced mouse NPGL peptide containing 80 amino acid residues, identical to the rat NPGL sequence, was synthesized by microwave-assisted solid-phase peptide synthesis using an automated peptide synthesizer (Syro Wave; Biotage, Uppsala, Sweden) as previously described (11) . Guinea pig and rabbit antisera were produced as previously described (6, 7) using synthetic NPGL as the antigen. The antigen solution was mixed with Freund's complete adjuvant and injected into guinea pigs and rabbits. After a booster injection, blood was collected from each animal and the optimal serum with high titer was selected by a dot blot analysis. Anti-NPGL antibody was purified on an NPGLconjugated Sepharose 6B column. 
Immunohistochemistry
Male mice (8 weeks old) were injected with colchicine into lateral ventricle (30 mg/2.5 mL). After 2 days, the brains were cut on 20-or 60-mm sections with a cryostat at 220°C following cryoprotection and freezing. The procedure using immunoenzyme and immunofluoroscence staining on floating sections was conducted as described previously (8, 9, 12) . Briefly, for the enzyme-labeled antibody method, the sections were incubated in blocking buffer (1% bovine serum albumin, 1% normal goat serum, and 0.3% Triton X-100 in 10 mM phosphate-buffered saline) for 1 hour after incubating with 3% H 2 O 2 in absolute methanol for 30 minutes at room temperature. Subsequently, sections were incubated in the guinea pig antibody against NPGL (1:500 dilution in blocking buffer) overnight at 4°C, and then with goat antiguinea pig immunoglobulin G (IgG; 1:1000 dilution; Vector Laboratories, Burlingame, CA). Immunoreactive products were detected with an ABC kit (Vectastain Elite kit; Vector Laboratories). A control experiment was performed to examine antibody specificity by preadsorbing the working dilution of the primary antibody with a saturating concentration (10 mg/mL) of NPGL.
For the immunofluorescence method, the sections were incubated in blocking buffer (1% bovine serum albumin, 1% normal donkey serum, and 0.3% Triton X-100 in 10 mM phosphate-buffered saline) for 1 hour at room temperature before incubating with the rabbit antibody against NPGL (1:250 dilution in blocking buffer) overnight at 4°C. Cy3-conjugated donkey anti-rabbit IgG (1:400 dilution, 711-165-152; Jackson ImmunoResearch Laboratories, West Grove, PA) was used as a secondary antibody.
Interactions of NPGL-immunoreactive fibers with NPY/ AgRP or POMC neurons were surveyed using double-label immunofluorescence as follows: a guinea pig antibody against NPGL (1:500 dilution) and a rabbit antibody against AgRP (1:10,000 dilution, H-003-57; Phoenix Pharmaceuticals, Burlingame, CA) were used for the detection of NPGL fibers and NPY/AgRP neurons, and a rabbit antibody against NPGL (1:250 dilution) and a guinea pig antibody against human b-endorphin (1:2000 dilution, T-5009; Peninsula Laboratories, San Carlos, CA) were used for the detection of NPGL fibers and POMC neurons. Cy3-conjugated donkey anti-rabbit IgG (1:400 dilution, 711-165-152; Jackson ImmunoResearch Laboratories) and Alexa Fluor 488-conjugated donkey anti-guinea pig IgG (1:600 dilution, 706-545-148; Jackson ImmunoResearch Laboratories) were used as secondary antibodies. Immunoreactive labeling was observed using an Eclipse E600 conventional microscope (Nikon, Tokyo, Japan) or a FV1000 confocal microscope (Olympus, Tokyo, Japan).
Intracerebroventricular injection
Male mice (8 weeks old) were used. A guide cannula (22 gauge, C313GS-5; Plastics One, Roanoke, VA) was fixed to the skull using acrylic resin (Shofu, Kyoto, Japan). The final coordinates of the guide cannula tips were 0.2 mm caudal to bregma, 1.0 mm lateral to midline, and 1.25 mm ventral to the skull surface. The injector (28 gauge, C313IS-5; Plastics One) was extended to 1.0 mm below the tip of the guide cannula. Injections were delivered by a syringe (Hamilton, Bonaduz, Switzerland) connected to polyethylene tubing using a syringe pump controller (BASi, West Lafayette, IN). The injection of reagents was performed after a postoperative period of 10 days. NPGL was diluted in 30% propylene glycol at pH 8.0 and the injection dose was 1.0 nmol per animal. The vehicle of 30% propylene glycol at pH 8.0 was used as a control. The injection was conducted at the beginning of light period and food intake was measured at 1, 2, 4, 6, 8, 10, and 24 hours after the injection.
Measurement of serum glucose concentration
Serum glucose concentration was measured by a Glucocard G+ meter (Arkray, Kyoto, Japan).
Statistical analysis
Statistically significant differences were calculated using a Student t test or a one-way analysis of variance. Differences at P values of ,0.05 were considered statistically significant.
Results
Cloning of cDNA encoding the mouse NPGL precursor
The cDNA sequence encoding NPGL was determined using total RNA isolated from the mouse hypothalamus. The open reading frame was 546 bp, and the deduced protein consisted of 181 amino acid residues [ Fig. 1(a) ]. The precursor protein includes a 33-amino acid signal peptide at the N terminus, an 80-amino acid residue small protein, a Gly amidation signal and a dibasic cleavage site (Arg-Arg) at the C terminus of the small protein, and an extended C-terminal sequence [ Fig. 1(a) ]. Additionally, NPGL contains two Cys residues, suggesting disulfide bond formation [ Fig. 1(a) ]. The amino acid sequence alignment of NPGL proteins deduced from the cDNA of mouse and chicken is shown in Fig. 1(b) . The amino acid sequence similarity of NPGL between the mouse and chicken is 85%.
Expression of the NPGL precursor mRNA in the brain
The expression levels of the NPGL precursor mRNA within different regions of the brain, including the telencephalon, diencephalon, mesencephalon, cerebellum, and MBH, were examined by real-time RT-PCR. The NPGL precursor mRNA was exclusively expressed in the MBH, whereas expression in other brain regions was around background levels (Fig. 2) .
Morphological analysis
The localization of the NPGL-containing cells in the brain was further analyzed by in situ hybridization and immunohistochemistry. Fig. 3(a) schematically shows the localization of NPGL-containing cell bodies (filled circles) and fibers (open circles) in the MBH. In situ hybridization revealed that cells expressing the NPGL precursor mRNA were specifically distributed in the lateroposterior part of the Arc (ArcLP) within the MBH [ Fig. 3(b) and 3(c) ]. Positive signals were detected by the antisense probe [ Fig. 3(b) and 3(c) ], but not by the sense probe [ Fig. 3(d) ]. Immunohistochemistry also showed that NPGL-immunoreactive cell bodies and fibers were localized in the ArcLP within the MBH [ Fig.  3(e) ]. Cell and fiber labeling were absent in preadsorption experiments [ Fig. 3(f) ]. The colchicine treatment enabled the detection of NPGL-immunoreactive cells. NPGL-immunoreactive fibers were distributed in the lateral part of the Arc (ArcL), around the ventromedial hypothalamus (VMH), near the third ventricle [ Fig. 3 (g) and 3(h)], and between the dorsomedial hypothalamus (DMH) and the posterior hypothalamus [ Fig. 3(a) , 3(g), and 3(h)]. The interactions of NPGL neurons with other well-known neuropeptides regulating feeding, that is, NPY/AgRP or POMC neurons, were investigated in the rostral regions of the Arc. NPGLimmunoreactive fibers were found in close apposition to POMC neurons in the ArcL but not NPY/AgRP neurons (Fig. 4) . Using confocal microscopy, NPGL-immunoreactive fibers were found to contact POMC neurons [ Fig.  4(f-h) ].
Expression of the NPGL precursor mRNA under fasting
As the location of NPGL cell bodies and projections in the hypothalamus pointed to a potential role for this protein in energy metabolic regulation (13), we examined the response of NPGL to a negative energy balance. The expression of NPGL precursor mRNA was examined after 24 hours of fasting. The expression level of NPGL was significantly higher in fasted mice relative to nonfasted mice [ Fig. 5(a) ]. Although both fasted and nonfasted mice showed similar serum glucose levels [ Fig. 5(b) ], body weight significantly decreased in fasted mice [ Fig. 5(c) ]. (d and h) . Each value represents the mean 6 standard error of the mean (n = 5 to 6). *P , 0.05, **P , 0.001.
Expression of the NPGL precursor mRNA under short-or long-term exposure to HFD
The increased expression of NPGL in fasted mice suggested that this protein may serve to signal a negative energy balance. To further examine this possibility, we explored whether NPGL expression would be decreased during a positive energy state. When mice were fed HFD for 5 weeks beginning at 4 weeks of age, the expression level of the NPGL precursor mRNA was significantly reduced in HFD-fed mice [ Fig. 6(a) ]. It is known that HFD intake induces an increase in a hypothalamic Socs3 that serves to inhibit leptin signaling, eventually leading to obesity in HFD-fed mice (14) . Therefore, we measured the Socs3 mRNA expression level and body weight in normal chow-and HFD-fed mice. Contrary to expectation, significant differences were not detected in both parameters [ Fig. 6 (b) and 6(c)]. However, serum glucose levels were significantly elevated in HFD-fed mice [ Fig. 6(d) ].
When mice were fed HFD for 13 weeks beginning at 4 weeks of age, NPGL precursor mRNA expression levels in HFD-fed mice did not differ from those of control mice [ Fig. 6(e) ]. Socs3 mRNA expression levels and body weight significantly increased in HFD-fed mice [ Fig. 6 (f) and 6(g)]. Serum glucose levels were significantly higher in HFD-fed mice than in normal chow-fed mice, as well as mice fed for 5 weeks [ Fig. 6(h) ].
Effect of NPGL on food intake
Because NPGL precursor mRNA expression levels were upregulated by fasting and downregulated by shortterm HFD feeding, we predicted that NPGL acts as an orexigenic neuropeptide in mice. To examine this possibility, we administered NPGL, mature protein, into the lateral ventricle at the beginning of light period, and measured food intake at 1, 2, 4, 6, 8, 10, and 24 hours after the intracerebroventricular injection. Cumulative food intake significantly increased about 2.5-fold after 2 hours from the injection, and about twofold after 4, 6, 8, and 10 hours [ Fig. 7(a) ]. A significant difference was not detected after 24 hours from the injection [ Fig. 7(a) ]. Food intake per unit time significantly increased 3.3-fold from 1 to 2 hours, 2.9-fold from 4 to 6 hours, and 1.6-fold from 6 to 8 hours after injection [ Fig. 7(b) ]. This result indicates that the orexigenic effect of NPGL deteriorated over time but was sustained for at least 8 hours [ Fig. 7(b) ].
Discussion
We have recently reported that the mRNA encoding NPGL, a hypothalamic small secretory protein, is expressed in the chicken hypothalamus, and NPGL may participate in the growth process in chicks (5) . We speculated that the NPGL precursor gene is conserved in vertebrates, including mammals, a possibility confirmed via a database search (5) . The present study shows the cloning of NPGL cDNA and the identification of NPGL neurons in the mammalian brain. Furthermore, NPGL precursor mRNA expression levels are elevated by fasting and reduced by short-term HFD feeding, and central injections of NPGL increase food intake. Taken together, these results suggest that NPGL is an orexigenic neuropeptide in mice.
Quantitative RT-PCR and morphological analyses revealed that NPGL neurons are located in the ArcLP within the MBH. The rostral region of the Arc in the hypothalamus is one of the centers of energy metabolic regulation and contains two major neuronal populations (i.e., NPY/AgRP neurons and POMC neurons) (2, 15) . NPY/AgRP neurons promote food intake and decrease energy expenditure, whereas POMC neurons have the opposite effect (13) . mRNA expression levels of NPY and POMC change in response to energetic status to maintain energy homeostasis (13) . In the present study, double-label immunofluorescence revealed that NPGL-immunoreactive fibers form close contacts with POMC neurons in the ArcL. This result suggests that NPGL may stimulate feeding behavior through inhibition of anorexigenic POMC neurons. In addition to the ArcL, NPGL neuronal fibers were also observed in the DMH and VMH. Several neuropeptidergic cell phenotypes that regulate food intake are distributed in the DMH and VMH. In particular, a population of NPY cells is found in the DMH in addition to the ArcL (16) . NPY cells in this region, as well as in the ArcL, stimulate food intake (17) . A few cell bodies expressing melanin-containing hormone and orexin/hypocretin are also found in the DMH, although most of these cells are located in the lateral hypothalamic area (18) . Both melanin-containing hormone and orexin/hypocretin neurons promote food intake (19, 20) . In the VMH, pituitary adenylate cyclase-activating polypeptide cells are expressed (21) , and central injections of pituitary adenylate cyclase-activating polypeptide inhibit food intake (22) . Thus, NPGL may regulate food intake by acting via these well-established mechanisms of energetic control.
A negative energy balance induced by fasting elevated the expression of NPGL precursor mRNA, suggesting that NPGL has orexigenic properties in mice. As mentioned previously, fasting increases orexigenic neuropeptides such as NPY (23, 24) and agouti-related protein (AgRP) (24, 25) . Further support for an orexigenic role of NPGL comes from the fact that injection of NPGL increased food intake. Because serum glucose levels were not affected by fasting in this study, it is likely that changes in NPGL expression are not a result of changes in glucose. In contrast, HFD feeding for 5 weeks, but not 13 weeks (a positive energy balance), reduced the expression of NPGL precursor mRNA. Extended maintenance on a HFD impairs central leptin sensitivity, increases body weight, and inevitably leads to leptin resistance and obesity (26, 27) , in part through increased hypothalamic Socs3 expression (14, 28) . In the present study, short-term (5 weeks) HFD significantly decreased NPGL precursor mRNA without affecting body weight and Socs3 mRNA expression. This result suggests that leptin continues to play an antiobesity role in short-term HFD-fed mice to prevent dietinduced obesity. These findings suggest that NPGL neurons are responsive to leptin at this point. In contrast, in long-term (13 weeks) HFD-fed mice, NPGL precursor mRNA expression was not different from control levels, although Socs3 mRNA and body weight were increased. This result suggests that leptin resistance occurs in this stage. Taken together, these results point to the possibility that NPGL mRNA expression is reduced by leptin in short-term HFD-fed mice, and this reduction is not observed in long-term HFD-fed mice due to leptin resistance. In both short-and long-term HFD-fed mice, serum glucose levels were increased. This result suggests that serum glucose levels do not influence the expression of In summary, the present findings report on the cDNA encoding NPGL in the mouse hypothalamus, representing, to the authors' knowledge, the firstcharacterization of this neurochemical in the mammalian brain. NPGL neurons are localized to the ArcLP with fibers projecting to several areas of the hypothalamus mediating food intake and energy homeostasis, and especially POMC neurons. The mRNA expression level of the NPGL precursor is markedly, and predictably, impacted by energetic status, and central injections of NPGL increase food intake. Taken together, these findings point to NPGL as an orexigenic neuropeptide in mice and an important target for further study to fully understand the central mechanisms regulating energy homeostasis.
